- Home
- PROK vs CLPT Comparison
PROK vs CLPT Comparison
Compare PROK & CLPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- CLPT
- Stock Information
- Founded
- PROK 2015
- CLPT 1998
- Country
- PROK United States
- CLPT United States
- Employees
- PROK N/A
- CLPT N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- CLPT Medical/Dental Instruments
- Sector
- PROK Health Care
- CLPT Health Care
- Exchange
- PROK Nasdaq
- CLPT Nasdaq
- Market Cap
- PROK 384.2M
- CLPT 317.4M
- IPO Year
- PROK N/A
- CLPT N/A
- Fundamental
- Price
- PROK $2.17
- CLPT $10.87
- Analyst Decision
- PROK Buy
- CLPT Strong Buy
- Analyst Count
- PROK 5
- CLPT 3
- Target Price
- PROK $6.25
- CLPT $27.67
- AVG Volume (30 Days)
- PROK 1.7M
- CLPT 339.2K
- Earning Date
- PROK 08-12-2025
- CLPT 11-06-2025
- Dividend Yield
- PROK N/A
- CLPT N/A
- EPS Growth
- PROK N/A
- CLPT N/A
- EPS
- PROK N/A
- CLPT N/A
- Revenue
- PROK $527,000.00
- CLPT $33,593,000.00
- Revenue This Year
- PROK $265.05
- CLPT $22.34
- Revenue Next Year
- PROK N/A
- CLPT $25.50
- P/E Ratio
- PROK N/A
- CLPT N/A
- Revenue Growth
- PROK N/A
- CLPT 19.68
- 52 Week Low
- PROK $0.46
- CLPT $9.76
- 52 Week High
- PROK $7.13
- CLPT $19.22
- Technical
- Relative Strength Index (RSI)
- PROK 41.52
- CLPT 50.63
- Support Level
- PROK $2.23
- CLPT $10.08
- Resistance Level
- PROK $2.44
- CLPT $11.48
- Average True Range (ATR)
- PROK 0.15
- CLPT 0.49
- MACD
- PROK -0.02
- CLPT 0.06
- Stochastic Oscillator
- PROK 6.07
- CLPT 56.34
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About CLPT ClearPoint Neuro Inc.
ClearPoint Neuro Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. The company's ClearPoint system, which is in commercial use, is used to perform minimally invasive surgical procedures in the brain. The company's products include the ClearPoint system, ClearPoint Services, ClearPoint Disposables, ClearPoint Software, and ClearPoint Therapeutic Solutions.